Lanopepden (mesylate)

Lanopepden mesylate (GSK 1322322 mesylate) is a peptide deformase (PDF) inhibitor. Lanopepden mesylate has antibacterial activity by inhibiting the activity of PDF, preventing the correct synthesis of bacterial proteins. Lanopepden mesylate mainly targets Gram-positive bacteria. Lanopepden mesylate can be used in the study of acute bacterial skin and skin structural infections[1].

Product Specifications

CAS Number

[1441390-17-5]

Product Name Alternative

GSK 1322322 (mesylate)

UNSPSC

12352005

Target

Bacterial

Type

Reference compound

Related Pathways

Anti-infection

Applications

COVID-19-immunoregulation

Field of Research

Infection

Assay Protocol

https://www.medchemexpress.com/lanopepden-mesylate.html

Smiles

O=C([C@H](CC1CCCC1)CN(O)C=O)NNC2=NC(C)=NC(N3C[C@]4(COCCN4CC3)[H])=C2F.OS(C)(=O)=O

Molecular Formula

C23H38FN7O7S

Molecular Weight

575.65

References & Citations

[1]Lee H Y, et al. Identification of novel aminopiperidine derivatives for antibacterial activity against Gram-positive bacteria[J]. Bioorganic & Medicinal Chemistry Letters, 2016, 26 (13) : 3148-3152.